Institution
Good Hope Hospital
Healthcare•Birmingham, United Kingdom•
About: Good Hope Hospital is a healthcare organization based out in Birmingham, United Kingdom. It is known for research contribution in the topics: Erectile dysfunction & Cardiac resynchronization therapy. The organization has 507 authors who have published 442 publications receiving 10167 citations.
Topics: Erectile dysfunction, Cardiac resynchronization therapy, Population, Heart failure, Sexual function
Papers published on a yearly basis
Papers
More filters
TL;DR: A meta-analysis of these data and those of two published phase III trials showed a consistent benefit for the fludarabine plus cyclophosphamide regimen in terms of progression-free survival.
699 citations
Mayo Clinic1, Brown University2, University of Minnesota3, Johns Hopkins University4, University of North Carolina at Chapel Hill5, St Lukes Episcopal Hospital6, University of California, San Francisco7, Tufts University8, Good Hope Hospital9, University of Southern California10, University of Medicine and Dentistry of New Jersey11, University of Milan12, Cornell University13, SUNY Downstate Medical Center14, Maimonides Medical Center15, University of Manchester16
TL;DR: The Panel's recommendations build on those developed during the first and second Princeton Consensus Conferences, first emphasizing the use of exercise ability and stress testing to ensure that each man's cardiovascular health is consistent with the physical demands of sexual activity before prescribing treatment for ED, and second highlighting the link between ED and CVD, which may be asymptomatic and may benefit from cardiovascular risk reduction.
Abstract: The Princeton Consensus (Expert Panel) Conference is a multispecialty collaborative tradition dedicated to optimizing sexual function and preserving cardiovascular health. The third Princeton Consensus met November 8 to 10, 2010, and had 2 primary objectives. The first objective focused on the evaluation and management of cardiovascular risk in men with erectile dysfunction (ED) and no known cardiovascular disease (CVD), with particular emphasis on identification of men with ED who may require additional cardiologic work-up. The second objective focused on reevaluation and modification of previous recommendations for evaluation of cardiac risk associated with sexual activity in men with known CVD. The Panel's recommendations build on those developed during the first and second Princeton Consensus Conferences, first emphasizing the use of exercise ability and stress testing to ensure that each man's cardiovascular health is consistent with the physical demands of sexual activity before prescribing treatment for ED, and second highlighting the link between ED and CVD, which may be asymptomatic and may benefit from cardiovascular risk reduction.
384 citations
TL;DR: This paper reviews the available evidence for a link between exercise and large bowel cancer and concludes that physical activity may be associated with reduced risk of colorectal cancer.
Abstract: Background Physical activity may be associated with reduced risk of colorectal cancer. The main aim of this paper is to review the available evidence for a link between exercise and large bowel cancer.
Methods A Cochrane-type methodology was performed. Data extracted included, type of study, type of physical activity measured and the numerical results. The risk ratios (RR) of the studies have been pooled according to the type of study, type of exercise, type of cancer and sex. Pooling was undertaken using fixed effect meta-analysis. A random effect meta-analysis was used where substantial heterogeneity existed.
Result Data from 19 cohort studies showed a statistically significant reduction in the risk of colon cancer in physically active males, RR being 0.79 (95% CI 0.72–0.87) and 0.78 (95% CI 0.68–0.91) for occupational and recreational activities, respectively. In women only recreational activities are protective against colon cancer (RR = 0.71, 95%CI 0.57–0.88). Case-control studies showed significantly reduced risks of colon cancer in both sexes irrespective of the type of activity. No protection against rectal cancer is seen in either sex.
Conclusion There is considerable evidence that physical activity is associated with reduced risk of colon cancer in both males and females.
354 citations
TL;DR: Clinical evidence supports the use of phosphodiesterase 5 (PDE5) inhibitors as first‐line therapy in men with CAD and comorbid ED and those with diabetes and ED (Level 1, Grade A).
Abstract: * A significant proportion of men with erectile dysfunction (ED) exhibit early signs of coronary artery disease (CAD), and this group may develop more severe CAD than men without ED (Level 1, Grade A). * The time interval among the onset of ED symptoms and the occurrence of CAD symptoms and cardiovascular events is estimated at 2-3 years and 3-5 years respectively; this interval allows for risk factor reduction (Level 2, Grade B). * ED is associated with increased all-cause mortality primarily due to increased cardiovascular mortality (Level 1, Grade A). * All men with ED should undergo a thorough medical assessment, including testosterone, fasting lipids, fasting glucose and blood pressure measurement. Following assessment, patients should be stratified according to the risk of future cardiovascular events. Those at high risk of cardiovascular disease should be evaluated by stress testing with selective use of computed tomography (CT) or coronary angiography (Level 1, Grade A). * Improvement in cardiovascular risk factors such as weight loss and increased physical activity has been reported to improve erectile function (Level 1, Grade A). * In men with ED, hypertension, diabetes and hyperlipidaemia should be treated aggressively, bearing in mind the potential side effects (Level 1, Grade A). * Management of ED is secondary to stabilising cardiovascular function, and controlling cardiovascular symptoms and exercise tolerance should be established prior to initiation of ED therapy (Level 1, Grade A). * Clinical evidence supports the use of phosphodiesterase 5 (PDE5) inhibitors as first-line therapy in men with CAD and comorbid ED and those with diabetes and ED (Level 1, Grade A). * Total testosterone and selectively free testosterone levels should be measured in all men with ED in accordance with contemporary guidelines and particularly in those who fail to respond to PDE5 inhibitors or have a chronic illness associated with low testosterone (Level 1, Grade A). * Testosterone replacement therapy may lead to symptomatic improvement (improved wellbeing) and enhance the effectiveness of PDE5 inhibitors (Level 1, Grade A). * Review of cardiovascular status and response to ED therapy should be performed at regular intervals (Level 1, Grade A).
216 citations
TL;DR: A meta-analysis on the effect of TS on male sexual function and its synergism with the use of phosphodiesterase type 5 inhibitor (PDE5i) found that TS could be associated with an improvement in PDE5i outcome, but these results were not confirmed in placebo-controlled studies.
199 citations
Authors
Showing all 508 results
Name | H-index | Papers | Citations |
---|---|---|---|
Clifford J. Bailey | 61 | 287 | 15749 |
Kamran Rostami | 27 | 104 | 3551 |
Geoffrey Hackett | 26 | 73 | 2126 |
Kiran Patel | 25 | 67 | 8221 |
Sudarshan Ramachandran | 23 | 58 | 1901 |
David D. Pothier | 21 | 109 | 1824 |
Honest Honest | 19 | 24 | 1647 |
David O'Connor | 19 | 44 | 1242 |
S. Y. Iftikhar | 19 | 36 | 1578 |
Zaheer Yousef | 18 | 58 | 1160 |
Geoff Hackett | 18 | 48 | 2553 |
Shajil Chalil | 17 | 32 | 1200 |
David N Naumann | 17 | 74 | 822 |
Karim Ratib | 16 | 33 | 1262 |
Stephen T. Ward | 16 | 53 | 812 |